APA (7th ed.) Citation

Schwaab, J., Naumann, N., Lübke, J., Jawhar, M., Somervaille, T. C., Williams, M. S., . . . Metzgeroth, G. (2020). Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes. American journal of hematology, 95(7), . https://doi.org/10.1002/ajh.25825

Chicago Style (17th ed.) Citation

Schwaab, Juliana, et al. "Response to Tyrosine Kinase Inhibitors in Myeloid Neoplasms Associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 Fusion Genes." American Journal of Hematology 95, no. 7 (2020). https://doi.org/10.1002/ajh.25825.

MLA (9th ed.) Citation

Schwaab, Juliana, et al. "Response to Tyrosine Kinase Inhibitors in Myeloid Neoplasms Associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 Fusion Genes." American Journal of Hematology, vol. 95, no. 7, 2020, https://doi.org/10.1002/ajh.25825.